MP:0001222 | epidermal hyperplasia | "increase in size of the epidermis due to increase in epidermal cell number" [Stedman s Medical Dictionary:ISBN 0-683-40008-8, J:65146] |
Show
Allelic Composition: Svs2tm2Kemi/Svs2tm2Kemi,Tg(CAG-RFP,Acr-EGFP)RBGS002Osb/0 Genetic Background: involves: 129 * C57BL/6 * C57BL/6N * DBA/2
|
MP:0001516 | abnormal motor coordination/ balance | "altered ability of an animal to maintain skillful and effective interaction of movements or maintenance of equilibrium" [csmith:Cynthia L. Smith , Mouse Genome Informatics Curator] |
Show
Allelic Composition: Bmpr2tm1Kmi/Bmpr2+,Btg2tm1Spo/Btg2tm1Spo Genetic Background: involves: 129S4/SvJae * C57BL/6
|
MP:0002020 | increased tumor incidence | "greater than average number of tumors, usually a specific type" [MGI:cls, J:34193] |
Show
Allelic Composition: Krastm4Tyj/Kras+,Plcl1tm1.1Matk/Plcl1tm1.1Matk Genetic Background: involves: 129S4/SvJae * C57BL/6
|
MP:0002064 | seizures | "sudden and often acute manifestation of epileptic attack, sometimes convulsive" [csmith:Cynthia L. Smith , Mouse Genome Informatics Curator] |
Show
Allelic Composition: Dnase2atm1Osa/Dnase2atm1Osa,Ifnar1tm1Agt/Ifnar1tm1Agt Genetic Background: involves: 129S1/Sv * 129S2/SvPas * 129X1/SvJ * C57BL/6
|
MP:0002272 | abnormal nervous system electrophysiology | "anomaly in the function of the nervous system as it relates to electrical phenomena" [cwg:Carroll-Ann W. Goldsmith , Mouse Genome Informatics curator] |
Show
Allelic Composition: Bmpr2tm1Kmi/Bmpr2+,Btg2tm1Spo/Btg2tm1Spo Genetic Background: involves: 129S4/SvJae * C57BL/6
|
MP:0002906 | susceptibility to pharmacologically induced seizures | "inability to withstand doses of pharmacological drugs that induce seizure activity in normal animals" [csmith:Cynthia L. Smith , Mouse Genome Informatics Curator, J:69504] |
Show
Allelic Composition: Dnase2atm1Osa/Dnase2atm1Osa,Ifnar1tm1Agt/Ifnar1tm1Agt Genetic Background: involves: 129S1/Sv * 129S2/SvPas * 129X1/SvJ * C57BL/6
|
MP:0003721 | increased tumor growth/size | "greater than expected development of tumorous growth when compared to controls" [smb:Susan M Bello, Mouse Genome Informatics Curator] |
Show
Allelic Composition: Svs2tm2Kemi/Svs2tm2Kemi,Tg(CAG-RFP,Acr-EGFP)RBGS002Osb/0 Genetic Background: involves: 129 * C57BL/6 * C57BL/6N * DBA/2
|
MP:0004499 | increased incidence of chemically-induced tumors | "higher than normal frequency of tumor incidence induced by one or more chemical carcinogens or mutagens" [MGI:smb "Susan M. Bello, Mouse Genome Informatics Curator"] |
Show
Allelic Composition: Svs2tm2Kemi/Svs2tm2Kemi,Tg(CAG-RFP,Acr-EGFP)RBGS002Osb/0 Genetic Background: involves: 129 * C57BL/6 * C57BL/6N * DBA/2
Allelic Composition: Plcl1tm1.1Matk/Plcl1tm1.1Matk Genetic Background: involves: C57BL/6 * FVB
Allelic Composition: Plcl1tm2.1Matk/Plcl1tm2.1Matk Genetic Background: FVB.Cg-Plcl1tm2.1Matk
|
MP:0009747 | impaired behavioral response to xenobiotic | "decreased sensitivity to a foreign compound capable of inducing the appearance of behavioral response, such as consumption preference, induced hyperactivity or stereotypic behavior, or increased dosage threshold for the appearance of the behavioral response" [MGI:csmith "Cynthia L. Smith, Mouse Genome Informatics Curator"] |
Show
Allelic Composition: Bmpr2tm1Kmi/Bmpr2+,Btg2tm1Spo/Btg2tm1Spo Genetic Background: involves: 129S4/SvJae * C57BL/6
|
MP:0009766 | increased sensitivity to xenobiotic induced morbidity/mortality | "decrease in the amount of a foreign compound required to cause death or diseased state" [MGI:smb "Susan M. Bello, Mouse Genome Informatics Curator"] |
Show
Allelic Composition: Dnase2atm1Osa/Dnase2atm1Osa,Ifnar1tm1Agt/Ifnar1tm1Agt Genetic Background: involves: 129S1/Sv * 129S2/SvPas * 129X1/SvJ * C57BL/6
Allelic Composition: Plcl1tm1.1Matk/Plcl1tm1.1Matk Genetic Background: FVB.Cg-Plcl1tm1.1Matk
|